O sistema complemento (SC) é um importante componente da imunidade inata na eliminação de patógenos. Suas proteínas reguladoras são necessárias para controlar a excessiva ativação sobre células próprias. Porém, alguns patógenos ligam a estas proteínas reguladoras para escapar do SC. A Leptospira spp. - agente etiológico do leptospirose - interage com Fator H e C4BP permitindo a evasão ao SC. As regiões SCR 7 e 8 da C4BP são responsáveis pela interação com proteínas LcpA e LigBC, e os SCRs 4, 7 e 8 são responsáveis pela interação com LigAC e L. interrogans íntegra. Estas interaçôes são dependentes de forças iônicas e inibidas por heparina. Outro importante regulador da via clássica e das lectinas é o inibidor de C1 esterase. Observamos sua a interação com leptospira atenuada, patogênica e não patogênica. Ensaios de sobrevivência de leptospira sugerem sua importância na sobrevida de leptospira atenuada, podendo ser utilizado como mecanismo de escape à via clássica e das lectinas do SC, sendo o primeiro mecanismo deste tipo, investigado em leptospiras. / Leptospirosis is a zoonosis caused by bacteria Leptospira. The Complement System plays a crucial role in the immune response against Leptospira. Non-pathogenic leptospira is eliminated by complement while pathogenic is able to avoid complement activation by the acquisition of host complement inhibitors Factor H and C4BP. We verified that SCR 7 and 8 of C4BP alpha chain are responsible to interaction with outer membrane proteins of L. interrogans LcpA and LigBC while SCR 4, 7 and 8 are responsible to interaction with LigAC and L. interrogans. We characterized this protein-protein interaction and verified that is ionic strength dependent and is inhibited by heparin. C1INH, another important regulator of classical and lectin pathways, interacts with the surface of leptospiras pathogenic, non-patogenic and attenuated and it is still able to regulates the classical pathway. We also performed a killing experiment and verified that C1INH is important to the survival of leptospiras attenuated, been the first complement system evasion mechanisms verified at this strain.

O sistema complemento (SC) é um importante componente da imunidade inata na eliminação de patógenos. Suas proteínas reguladoras são necessárias para controlar a excessiva ativação sobre células próprias. Porém, alguns patógenos ligam a estas proteínas reguladoras para escapar do SC. A Leptospira spp. - agente etiológico do leptospirose - interage com Fator H e C4BP permitindo a evasão ao SC. As regiões SCR 7 e 8 da C4BP são responsáveis pela interação com proteínas LcpA e LigBC, e os SCRs 4, 7 e 8 são responsáveis pela interação com LigAC e L. interrogans íntegra. Estas interaçôes são dependentes de forças iônicas e inibidas por heparina. Outro importante regulador da via clássica e das lectinas é o inibidor de C1 esterase. Observamos sua a interação com leptospira atenuada, patogênica e não patogênica. Ensaios de sobrevivência de leptospira sugerem sua importância na sobrevida de leptospira atenuada, podendo ser utilizado como mecanismo de escape à via clássica e das lectinas do SC, sendo o primeiro mecanismo deste tipo, investigado em leptospiras. / Leptospirosis is a zoonosis caused by bacteria Leptospira. The Complement System plays a crucial role in the immune response against Leptospira. Non-pathogenic leptospira is eliminated by complement while pathogenic is able to avoid complement activation by the acquisition of host complement inhibitors Factor H and C4BP. We verified that SCR 7 and 8 of C4BP alpha chain are responsible to interaction with outer membrane proteins of L. interrogans LcpA and LigBC while SCR 4, 7 and 8 are responsible to interaction with LigAC and L. interrogans. We characterized this protein-protein interaction and verified that is ionic strength dependent and is inhibited by heparin. C1INH, another important regulator of classical and lectin pathways, interacts with the surface of leptospiras pathogenic, non-patogenic and attenuated and it is still able to regulates the classical pathway. We also performed a killing experiment and verified that C1INH is important to the survival of leptospiras attenuated, been the first complement system evasion mechanisms verified at this strain.

Diferentes mecanismos têm sido mostrados por estar envolvidos na evasão à morte mediada por complemento. Neste estudo, demonstramos que a aquisição do FH pela Leptospira é crucial para a sobrevivência das bactérias no soro e que estas espiroquetas interagem com FH, FHL-1, FHR-1 e C4BP. Nós também demonstramos que a ligação à estes reguladores é mediada pelas proteínas leptospiral immunoglobulin-like (Lig). FH se liga as proteínas Lig via short consensus repeat (SCR) principalmente pelos domínios 5 e 20. Ensaios de competição sugerem que FH e C4BP têm sítios de ligação diferentes nas proteínas Lig. Além disso, FH e C4BP ligados nas proteínas Lig mantêm a atividade de cofator, mediando a degradação de C3b e C4b pelo FI. Nós demonstramos que a aquisição de FH e C4BP pela L. biflexa transgênica para LigA e LigB exercem um papel de proteção na sobrevida destas bactérias. Análise por citometria de fluxo também confirmaram a capacidade das leptospiras transgênicas para controlar a deposição de C3, C4 e MAC. As proteínas Lig também foram capazes de ligar plasminogênio, o qual foi ativado em plasmina e esta enzima foi capaz de degradar fibrinogénio, C3b e C5. Estas clivagens inativam C3b e C5, evitando a progressão da cascata, e bloqueando as três vias de complemento. / Different mechanisms have been shown to be involved in evasion of complement-mediated killing. In this study, we demonstrate that acquisition of FH on the Leptospira surface is crucial for bacterial survival in the serum and that these spirochetes interact with FH, FHL-1, FHR-1 and C4BP. We also demonstrate that binding to these regulators is mediated by leptospiral immunoglobulin-like (Lig) proteins. FH binds to Lig proteins via short consensus repeat (SCR) domains 5 and 20. Competition assays suggest that FH and C4BP have distinct binding sites on Lig proteins. Moreover, FH and C4BP bound to immobilized Ligs display cofactor activity, mediating C3b and C4b degradation by FI. We demonstrated that acquisition of FH and C4BP by the LigA and LigB transformed L. biflexa have the protective role, being crucial by bacterial survival. Analysis by Cytometer fluid also confirmed the ability of L. biflexa expressing LigA and LiB to controller the deposition of C3, C4 and MAC. Lig proteins were able to bind plasminogen, which was activated to plasmin and this enzyme was able to degrade the fibrinogen, C3b and C5. These cleavages inactivate C3b and C5, preventing progression of the complement cascade and blocking the three complement pathways.

Diferentes mecanismos têm sido mostrados por estar envolvidos na evasão à morte mediada por complemento. Neste estudo, demonstramos que a aquisição do FH pela Leptospira é crucial para a sobrevivência das bactérias no soro e que estas espiroquetas interagem com FH, FHL-1, FHR-1 e C4BP. Nós também demonstramos que a ligação à estes reguladores é mediada pelas proteínas leptospiral immunoglobulin-like (Lig). FH se liga as proteínas Lig via short consensus repeat (SCR) principalmente pelos domínios 5 e 20. Ensaios de competição sugerem que FH e C4BP têm sítios de ligação diferentes nas proteínas Lig. Além disso, FH e C4BP ligados nas proteínas Lig mantêm a atividade de cofator, mediando a degradação de C3b e C4b pelo FI. Nós demonstramos que a aquisição de FH e C4BP pela L. biflexa transgênica para LigA e LigB exercem um papel de proteção na sobrevida destas bactérias. Análise por citometria de fluxo também confirmaram a capacidade das leptospiras transgênicas para controlar a deposição de C3, C4 e MAC. As proteínas Lig também foram capazes de ligar plasminogênio, o qual foi ativado em plasmina e esta enzima foi capaz de degradar fibrinogénio, C3b e C5. Estas clivagens inativam C3b e C5, evitando a progressão da cascata, e bloqueando as três vias de complemento. / Different mechanisms have been shown to be involved in evasion of complement-mediated killing. In this study, we demonstrate that acquisition of FH on the Leptospira surface is crucial for bacterial survival in the serum and that these spirochetes interact with FH, FHL-1, FHR-1 and C4BP. We also demonstrate that binding to these regulators is mediated by leptospiral immunoglobulin-like (Lig) proteins. FH binds to Lig proteins via short consensus repeat (SCR) domains 5 and 20. Competition assays suggest that FH and C4BP have distinct binding sites on Lig proteins. Moreover, FH and C4BP bound to immobilized Ligs display cofactor activity, mediating C3b and C4b degradation by FI. We demonstrated that acquisition of FH and C4BP by the LigA and LigB transformed L. biflexa have the protective role, being crucial by bacterial survival. Analysis by Cytometer fluid also confirmed the ability of L. biflexa expressing LigA and LiB to controller the deposition of C3, C4 and MAC. Lig proteins were able to bind plasminogen, which was activated to plasmin and this enzyme was able to degrade the fibrinogen, C3b and C5. These cleavages inactivate C3b and C5, preventing progression of the complement cascade and blocking the three complement pathways.

Several studies have shown that complement and thrombotic events co-exist. Platelets have been suspected to act as the bridge between the two cascade systems. To study the platelet-induced complement activation we developed a system in which platelets were activated by thrombin receptor activating peptide (TRAP) in platelet rich plasma (PRP) or whole blood anti-coagulated using the specific thrombin inhibitor, lepirudin. TRAP-activated platelets induced a fluid-phase complement activation measured as generation of C3a and sC5b-9, triggered by released chondroitin sulphate-A (CS-A) which interacted with C1q and activated the complement system through the classical pathway. Complement components C1q, C3, C4 and C9 were also shown to bind to TRAP-activated platelets but this binding did not seem to be due to a complement activation since blocking of complement activation at the C1q or C3 levels did not affect the binding of the complement proteins. The C3 which bound to activated platelets consisted of C3(H2O), indicating that bound C3 was not proteolytically activated. Binding of C1q was partially dependent on CS-A exposure on activated platelets. The abolished complement activation on the surface of activated platelets was suggested to be dependent on the involvement of several complement inhibitors. We confirmed the binding of C1INH and factor H to activated platelets. To this list we have added another potent complement inhibitor, C4BP. The binding of factor H and C4BP was shown to be dependent on exposure of CS-A on activated platelets. The physiological relevance of these reactions was reflected in an elevated expression of CD11b on leukocytes, and increased generation of platelet-leukocyte complexes. The platelets were involved in these events by at least two different mechanisms; generation of C5a which activated leukocytes and binding of C3(H2O)/iC3(H2O), a ligand to the intergrin CD11b/CD18 on their surface. These mechanisms add further to the understanding of how platelets interact with the complement system and will help us to understand the role of the complement system in cardiovascular disease and thrombotic conditions. / Platelet Mediated Complement Activation

Disturbances of host integrity have the potential to evoke activation of innate immunologic and hemostatic protection mechanisms in blood. Irrespective of whether the activating stimulus is typically immunogenic or thrombotic, it will generally affect both the complement system and platelets to a certain degree. The theme of this thesis is complement and platelet activity, which is intersected in all five included papers. The initial aim was to study the responses and mechanisms of the complement cascade in relation to platelet activation. The secondary aim was to use an applied approach to regulate platelets and complement on model biomaterial and cell surfaces.    Complement activation was found in the fluid phase in response to platelet activation in whole blood. The mechanism was traced to platelet release of stored chondroitin sulfate-A (CS-A) and classical pathway activation via C1q. C3 was detected at the platelet surface, though its binding was independent of complement activation. The inhibitors factor H and C4-binding protein (C4BP) were detected on activated platelets, and their binding was partly dependent on surface-exposed CS-A. Collectively, these results showed that platelet activation induces inflammatory complement activation in the fluid phase. CS-A was shown to be a central molecule in the complement-modulatory functions of platelets by its interaction with C1q, C4BP, and factor H. Platelet activation and surface adherence were successfully attenuated by conjugating an ADP-degrading apyrase on a model biomaterial. Only minor complement regulation was seen, and was therefore targeted specifically on surfaces and cells by co-immobilizing a factor H-binding peptide together with the apyrase. This combined approach led to a synchronized inhibition of both platelet and complement activation at the interface of biomaterials/xenogeneic cells and blood. In conclusion, here presents a novel crosstalk-mechanism for activation of complement when triggering platelets, which highlights the importance of regulating both complement and platelets to lower inflammatory events. In addition, a strategy to enhance the biocompatibility of biomaterials and cells by simultaneously targeting ADP-dependent platelet activation and the alternative complement C3-convertase is proposed.

Follicular dendritic cells (FDCs) reside in primary B-cell follicles and in the light zones of germinal centers (GCs) in secondary follicles, where their dendrites interdigitate forming extensive networks intimately interacting with B-cells. In GCs, FDCs can be found at the edges attached to the supporting reticular fibers. They trap and arrange immune complexes (ICs) in vivo and in vitro in a periodic manner with 200–500Å spacing and provide both antigen-specific and non-specific accessory signals to B-cells. FDCs exist in resting and activated states, with two characteristically different phenotypes. In their activated state, FDCs upregulate the expression of accessory molecules and cytokines important in the FDC-B cell interaction in GCs. We sought to determine the mechanisms influencing the transition of FDCs from a resting to an activated state in GCs and their impact on T-cell dependent (TD) and independent (TI)-GC reactions (GCRs). We found that IC-FDC interactions via FDC-FcgammaRIIB induce the upregulation of FDC-FcgammaRIIB, -ICAM-1, and -VCAM-1, at both the protein and mRNA levels. We also reported for the first time the expression of TLR-4 on FDCs. Moreover, engagement of FDC-TLR4 with LPS activated NF-kappaB, up-regulated expression of important FDC-accessory molecules, including FcgammaRIIB, ICAM-1, and VCAM-1, and enhanced FDC accessory activity in promoting recall IgG responses. Moreover, IC-activated FDCs produced IL-6 and FDC-IL-6 promoted GCRs, somatic hypermutation (SHM) and IgG production. Further, we reported that binding of FDCs to collagen coated surfaces induced restoration of their dendritic processes and networks in vitro. In addition, we designed an FDC-supported in vitro model capable of induction and assessment of primary human antibody responses to protein antigens characterized by class-switching and affinity maturation. Uniquely, we generated TI immune responses to TD protein Ags in the complete absence of T cell help in vivo and in vitro. In the presence of FDC-associated second signals such as BAFF and C4BP, FDC- FcgammaRIIB-periodically trapped-ICs induced the production of Ag-specific IgM, GC-development and plasmablast-differentiation in anti-Thy-1-pretreated nude mice. Purified murine and human B cells cultured in vitro with IC-bearing FDCs also showed the production of antigen–specific IgM within just 48 h.